https://www.**promotion blocked**.au/2022/05/13/which-is-the-better-beaten-up-buy-bubs-or-a2-milk-shares/
The broker Citi currently rates Bubs as a buy, with a price target of 59 cents. That implies a possible upside of around 57% on its current price of 37.5 cents. It noted the Chinese lockdowns could slow growth in the short term. It also noted Bubs’ new A2 beta-casein protein infant formula range, with the corporate daigou partner Willis Trading putting in an order valued at $32.9 million.Citi rates A2 Milk shares as a sell, with a price target of $4.80. Citi thinks that A2 Milk could suffer from the lockdowns.
BUB - US Exposure & The Current Baby Formula Shortage, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $138.4M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.5¢ | $203.4K | 1.298M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 632931 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 1369152 | 29 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| BUB (ASX) Chart |